148 related articles for article (PubMed ID: 22195036)
1. Plasma biomarkers for detecting Hodgkin's lymphoma in HIV patients.
Varnum SM; Webb-Robertson BJ; Hessol NA; Smith RD; Zangar RC
PLoS One; 2011; 6(12):e29263. PubMed ID: 22195036
[TBL] [Abstract][Full Text] [Related]
2. Characterization of HIV-associated Hodgkin's lymphoma in HIV-infected patients: a single-center experience.
Ruiz M; Parsons C; Cole J
J Int Assoc Physicians AIDS Care (Chic); 2012; 11(4):234-8. PubMed ID: 22302202
[TBL] [Abstract][Full Text] [Related]
3. Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy.
Bibas M; Trotta MP; Cozzi-Lepri A; Lorenzini P; Pinnetti C; Rizzardini G; Angarano G; Caramello P; Sighinolfi L; Mastroianni CM; Mazzarello G; Di Caro A; Di Giacomo C; d'Arminio Monforte A; Antinori A;
Am J Hematol; 2012 Aug; 87(8):749-53. PubMed ID: 22718364
[TBL] [Abstract][Full Text] [Related]
4. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
International Collaboration on HIV and Cancer
J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
[TBL] [Abstract][Full Text] [Related]
5. Hodgkin's lymphoma and its association with EBV and HIV infection.
Grewal R; Irimie A; Naidoo N; Mohamed N; Petrushev B; Chetty M; Tomuleasa C; Abayomi EA
Crit Rev Clin Lab Sci; 2018 Mar; 55(2):102-114. PubMed ID: 29316828
[TBL] [Abstract][Full Text] [Related]
6. Intracerebral Hodgkin's lymphoma in a patient with human immunodeficiency virus.
García-Noblejas A; Nieto S; Liberal R; Cannata J; Steegmann JL; Fernàndez-Rañada JM; Arranz R
Haematologica; 2007 Jun; 92(6):e72-3. PubMed ID: 17650454
[TBL] [Abstract][Full Text] [Related]
7. GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus.
Miralles P; Navarro JT; Berenguer J; Gómez Codina J; Kwon M; Serrano D; Díez-Martín JL; Villà S; Rubio R; Menárguez J; Ribera Santasusana JM
Med Clin (Barc); 2018 Jul; 151(1):39.e1-39.e17. PubMed ID: 29357988
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of AIDS defining & non-AIDS defining malignancies in north India.
Sachdeva RK; Sharma A; Singh S; Varma S
Indian J Med Res; 2016 May; 143(Supplement):S129-S135. PubMed ID: 27748287
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic characterization of TCR γδ T cells and MAIT cells in HIV-infected individuals developing Hodgkin's lymphoma.
Muller CKS; Spagnuolo J; Audigé A; Chancellor A; Russenberger D; Scherrer AU; Hoffmann M; Kouyos R; Battegay M; De Libero G; Speck RF;
Infect Agent Cancer; 2021 Apr; 16(1):24. PubMed ID: 33865435
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of human immunodeficiency virus-associated Hodgkin lymphoma patients in Japan.
Yotsumoto M; Hagiwara S; Ajisawa A; Tanuma J; Uehira T; Nagai H; Fujikawa Y; Maeda S; Kitano K; Arima N; Uno K; Iwai T; Hongo I; Ota Y; Fukutake K; Okada S
Int J Hematol; 2012 Aug; 96(2):247-53. PubMed ID: 22752537
[TBL] [Abstract][Full Text] [Related]
11. Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort.
Hleyhel M; Hleyhel M; Bouvier AM; Belot A; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
AIDS; 2014 Sep; 28(14):2109-18. PubMed ID: 25265077
[TBL] [Abstract][Full Text] [Related]
12. HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4⁺ T-cell lymphocytes.
Bohlius J; Schmidlin K; Boué F; Fätkenheuer G; May M; Caro-Murillo AM; Mocroft A; Bonnet F; Clifford G; Paparizos V; Miro JM; Obel N; Prins M; Chêne G; Egger M;
Blood; 2011 Jun; 117(23):6100-8. PubMed ID: 21368291
[TBL] [Abstract][Full Text] [Related]
13. Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma.
Xicoy B; Ribera JM; Miralles P; Berenguer J; Rubio R; Mahillo B; Valencia ME; Abella E; López-Guillermo A; Sureda A; Morgades M; Navarro JT; Esteban H; ;
Haematologica; 2007 Feb; 92(2):191-8. PubMed ID: 17296568
[TBL] [Abstract][Full Text] [Related]
14. Association of non-acquired immunodeficiency syndrome-defining cancers with human immunodeficiency virus infection.
Rabkin CS
J Natl Cancer Inst Monogr; 1998; (23):23-5. PubMed ID: 9709298
[TBL] [Abstract][Full Text] [Related]
15. Non-Hodgkin's lymphoma after prolonged remission of Hodgkin's disease in an HIV-infected patient.
Montalban C; Bellas C; Rodriguez-Garcia JL; Aguado M; Fernandez-Muñoz R
Ann Oncol; 1991 Sep; 2(8):585-7. PubMed ID: 1665342
[TBL] [Abstract][Full Text] [Related]
16. Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study.
Hessol NA; Whittemore H; Vittinghoff E; Hsu LC; Ma D; Scheer S; Schwarcz SK
Lancet HIV; 2018 Nov; 5(11):e647-e655. PubMed ID: 30245004
[TBL] [Abstract][Full Text] [Related]
17. Current treatment strategies for patients with Hodgkin's lymphoma and HIV infection.
Hartmann P; Rehwald U; Salzberger B; Franzen C; Diehl V
Expert Rev Anticancer Ther; 2004 Jun; 4(3):401-10. PubMed ID: 15161439
[TBL] [Abstract][Full Text] [Related]
18. Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort.
Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
Int J Cancer; 2015 Nov; 137(10):2443-53. PubMed ID: 25976897
[TBL] [Abstract][Full Text] [Related]
19. [HIV-associated malignant lymphomas].
Egli F; Baumann R; Bernasconi E; Opravil M
Schweiz Med Wochenschr; 1992 Apr; 122(14):495-502. PubMed ID: 1348590
[TBL] [Abstract][Full Text] [Related]
20. Peripheral Blood Cells from Patients with Hodgkin's and Diffuse Large B Cell Lymphomas May Be a Better Source of Candidate Diagnostic miRNAs Than Circulating miRNAs.
Paszkiewicz-Kozik E; Paziewska A; Kulecka M; Dąbrowska M; Kluska A; Bałabas A; Piątkowska M; Ambrożkiewicz F; Tajer J; Osiadacz W; Romejko-Jarosińska J; Kotarska M; Żeber-Lubecka N; Karczmarski J; Popławska L; Mikula M; Rutkowski P; Walewski J; Ostrowski J
Biomed Res Int; 2021; 2021():3212878. PubMed ID: 33628777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
